Semaphorin 4A maintains functional diversity of the hematopoietic stem cell pool

Dorsa Toghani(Fred Hutch Cancer Center), Lev Silberstein(Massachusetts General Hospital), Sharon Zeng(Fred Hutch Cancer Center), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Edie I. Crosse(MRC Centre for Regenerative Medicine), David M. Gravano(University of California, Merced), Atsushi Kumanogoh(The University of Osaka), Amogh Pradeep(Fred Hutch Cancer Center), Eric M. Pietras(University of Colorado Anschutz Medical Campus), Isabel Beerman(Boston Children's Hospital), Steven Z. Josefowicz(Cornell University), Peter V. Kharchenko(Fleet Science Center), Sarah Kinston(University of Cambridge), Daniel C. Jones(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Claus Nerlov(John Radcliffe Hospital), Stefan Radtke(Fred Hutch Cancer Center), Sónia Rodríguez(City of Hope), Marion Mesnieres(KU Leuven), Jin‐Gyu Cheong(Memorial Sloan Kettering Cancer Center), Hans‐Peter Kiem(Fred Hutch Cancer Center), Joel A. Spencer(Massachusetts General Hospital), Le Zong(Peking University), Negar Seyedhassantehrani(University of California, Merced), Christian Burns(University of California, Merced), Christa Maes(KU Leuven), Antonio Scialdone(Helmholtz Zentrum München), Nadia Carlesso(City Of Hope National Medical Center), Thomas Worzfeld(Philipps University of Marburg), Elmir Mahammadov(Helmholtz Munich), Nicola K. Wilson(University of Cambridge), Bongsoo Park(National Institute on Aging), David T. Scadden(Harvard University Press), Ali Toghani(Fred Hutch Cancer Center), Derek H. Janssens(Van Andel Institute), S. Gupte(Fred Hutch Cancer Center), Fabienne Lucas(Brigham and Women's Hospital)
bioRxiv (Cold Spring Harbor Laboratory)
November 13, 2024
Cited by 1


Related Papers